Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Reimbursement Changes May Impact Hospitals More Than Doctors

Executive Summary

Reimbursement changes for hospital outpatient drugs under the Medicare Modernization Act may have an even greater impact on hospitals than the transition to average sales price reimbursement for Part B drugs will have on physicians, Association of Community Cancer Centers Senior Director-Policy & Government Affairs Deborah Walter said

You may also be interested in...



Hospitals Should Be Reimbursed For Outpatient Rx Handling, MedPAC Says

The Hospital Outpatient Prospective Payment System should include a payment adjustment for pharmaceutical handling costs, the Medicare Payment Advisory Committee recommended during an April 21 meeting in Washington, D.C

Hospitals Should Be Reimbursed For Outpatient Rx Handling, MedPAC Says

The Hospital Outpatient Prospective Payment System should include a payment adjustment for pharmaceutical handling costs, the Medicare Payment Advisory Committee recommended during an April 21 meeting in Washington, D.C

Oncologists Embrace Part B Demo, Amgen Says; Big Test In Two Months

The Medicare Part B market is holding up well in the early weeks of 2005 thanks to a $300 mil. demonstration project unveiled in November, Amgen told analysts Jan. 27 in New York

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel